Posts Tagged ‘Clinical Trial’

Launch of a New Journal

Posted on: May 24th, 2019 by admin 1 Comment

The Society of Breast Imaging and Oxford University Press have recently launched the Journal of Breast Imaging (JBI), the first peer-reviewed journal […]

Diet Linked to Drug-Resistant Breast Cancer

Posted on: May 10th, 2019 by admin 2 Comments

Approximately 70% of all breast cancers are oestrogen-receptor positive (ER+), which means they rely on the hormone oestrogen to grow. As a result, oestrogen-blocking […]

New Guidelines Stir Up Controversy

Posted on: April 12th, 2019 by admin 1 Comment

A paper appeared earlier this week in the Annals of Internal Medicine entitled “Screening for breast cancer in average-risk women: a guidance […]

A Question of Equipoise

Posted on: March 22nd, 2019 by admin

Last week, Etta Pisano, who is chief research officer at the American College of Radiology, sat down for an interview with the […]

ABUS vs DBT – Again

Posted on: March 8th, 2019 by admin 2 Comments

The European Congress of Radiology, with a giant octopus in the registration area and a collage of aquatic images, concluded in […]

Thinking Outside of the Globe

Posted on: February 15th, 2019 by admin 3 Comments

Since 1980, the Canadian Space Agency (CSA) has been collaborating with its American counterpart NASA to develop and deploy sophisticated […]

A Breakthrough from Cape Town

Posted on: February 1st, 2019 by admin

Earlier this week, a woman with severe aortic valve stenosis was operated on successfully at Groote Schuur Hospital by Jacques Scherman, […]

FDA Hit by Government Shutdown

Posted on: January 4th, 2019 by admin 1 Comment

Just north of downtown Washington, DC, in suburban Maryland, lies the sprawling campus of the Food and Drug Administration (FDA), […]

NCI Launches Plans for 2020

Posted on: September 28th, 2018 by admin 1 Comment

A decade ago, when CapeRay was still being incubated within the University of Cape Town (UCT), we were successful in […]

Predicting the Return of Breast Cancer

Posted on: August 17th, 2018 by admin

Clinicians do not currently have a reliable way to predict which patients treated for hormone receptor-positive (HR+) breast cancer run […]